Literature DB >> 16334159

Impact of radiotherapy with and without concurrent cisplatin on lymphocyte subpopulations in cervical cancer patients.

Barbara Bachtiary1, Irene Herbacek, Thomas Zideck, Thomas-Hendrik Knocke, Johannes Dimopoulos, Richard Poetter, Michael Micksche.   

Abstract

BACKGROUND: The impact of radiotherapy alone (RT-alone) and radiotherapy plus concurrent chemotherapy with cisplatin (RT-CHT) was determined for lymphocyte subpopulations in cervical cancer patients.
MATERIALS AND METHODS: Thirty-four women were treated either with RT-alone (n=14) or RT-CHT (n=20). Peripheral lymphocytes were collected before, immediately after and 6, 12 and 24 weeks after completion of treatment. Flow cytometric analysis included total T-cells, T-helper-cells, T-suppressor-cells, T-cytotoxic-cells, NK-cells, B-cells and the CD4+/CD8+ratio.
RESULTS: Twenty-four weeks after treatment, B-cells had recovered to pretreatment levels whereas total lymphocyte counts, T-helper and T-cytotoxic-cells were still significantly reduced in both groups. In contrast, T-suppressor-cells and NK-cells had recovered to pretreatment levels only in patients who received RT-alone and were still significantly reduced in patients who received RT-CHT.
CONCLUSION: RT-alone and RT-CHT induce a significant and prolonged suppression of all lymphocyte subpopulations. RT-CHT, but not RT-alone, causes a prolonged suppression of NK-cells and T-suppressor cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16334159

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  6 in total

1.  Influence of chemoradiation on the immune microenvironment of cervical cancer patients.

Authors:  J M Herter; M Kiljan; S Kunze; M Reinscheid; O Ibruli; J Cai; L Niu; I Heßelmann; M Trommer; G S Herter-Sprie; C Köhler; S Marnitz
Journal:  Strahlenther Onkol       Date:  2022-10-17       Impact factor: 4.033

Review 2.  A Review of the Effects of Cervical Cancer Standard Treatment on Immune Parameters in Peripheral Blood, Tumor Draining Lymph Nodes, and Local Tumor Microenvironment.

Authors:  Iske F van Luijk; Sharissa M Smith; Maria C Marte Ojeda; Arlene L Oei; Gemma G Kenter; Ekaterina S Jordanova
Journal:  J Clin Med       Date:  2022-04-19       Impact factor: 4.964

3.  Lymphopenia and its association with survival in patients with locally advanced cervical cancer.

Authors:  Emily S Wu; Titilope Oduyebo; Lauren P Cobb; Diana Cholakian; Xiangrong Kong; Amanda N Fader; Kimberly L Levinson; Edward J Tanner; Rebecca L Stone; Anna Piotrowski; Stuart Grossman; Kara Long Roche
Journal:  Gynecol Oncol       Date:  2015-11-11       Impact factor: 5.482

4.  A phase I study of a combination of yttrium-90-labeled anti-carcinoembryonic antigen (CEA) antibody and gemcitabine in patients with CEA-producing advanced malignancies.

Authors:  Stephen Shibata; Andrew Raubitschek; Lucille Leong; Marianna Koczywas; Lawrence Williams; Jiping Zhan; Jeffrey Y C Wong
Journal:  Clin Cancer Res       Date:  2009-04-07       Impact factor: 12.531

5.  Association Between Radiation Tolerance of Lymphocytes and Clinical Outcomes in Cervical Cancer.

Authors:  Shiho Lee; Oyeon Cho; Mison Chun; Suk Jun Chang; Tae Wook Kong; Eun Ju Lee; Yonghee Lee
Journal:  In Vivo       Date:  2019 Nov-Dec       Impact factor: 2.155

6.  The effect of pelvic radiation alone on lymphocyte subgroups.

Authors:  Gregory P Swanson; Sameer G Jhavar; Kendall Hammonds
Journal:  Clin Transl Radiat Oncol       Date:  2020-05-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.